Abstract:To the Editors: In a recent article, Chen et al1 reported that an emm12 group A β-hemolytic streptococcus was responsible for the 2011 large outbreak of scarlet fever in Shanghai. There were fluctuations from 1 to 3 per 100,000 incidences of scarlet fever in 2007 to 2010 whereas the 2011 incidence rate peaked 16.04 per 100,000 in Pudong New Area, Shanghai. A 1:2 matched case-control study was conducted to explore risk factors with scarlet fever in Pudong New Area. A total of 167 patients with scarlet fever (104 male and 63 female; 7.03 ± 1.92 years of age), who were admitted to Center for Disease Control and Prevention of Pudong New Area from January 1, 2011 to April 30, 2012 were evaluated. All patients fulfilled the criteria of the Ministry of Health of the Republic of China. A total of 334 healthy children were included as control group, 1:2 matched for residency status (permanent resident or migrant), age (±3 months), gender and occupation. They came from the same community as cases. All the subjects gave informed consent. The questionnaire covered demographic data, clinical manifestations, laboratory results, living settings and exposures. All statistical analyses were performed by SPSS 10.01 (SPSS Inc., Chicago, IL). Univariate analysis was done to screen statistically significant variables. Then, a multiple logistic regression analysis was performed to calculate the multivariate-adjusted odds ratios for risk factors. The α level of model selection was set to be 0.10 for in-and-out models. Differences were considered statistically significant if P < 0.05 in 2-tailed tests. Univariate analysis revealed that 3 factors—group activity ≤1 week before onset, frequency of hospital visits ≤1 year before onset and frequency of respiratory diseases ≤1 year before onset—were significantly associated with scarlet fever (P < 0.05). Six factors—contact history with patients with respiratory diseases ≤1 week before onset, group activity ≤1 week before onset, travel history ≤1 week before onset, visiting a vaccination clinic ≤1 month before onset, frequency of hospital visit ≤1 year before onset and frequency of visiting hospital for respiratory diseases ≤1 year before onset—were put into a regression model. After adjusting by logistic regression, 2 factors—visiting a vaccination clinic ≤1 month before onset and frequency of hospital visit ≤1 year before onset (≥4 times)—remained significant risk factors associated with scarlet fever (Table, Supplemental Digital Content 1, https://links.lww.com/INF/B383). Scarlet fever has occurred sporadically in recent years with occasional outbreaks.2–4 In China, the incidence increased rapidly after October 2010. An outbreak hit Hong Kong in 2011, with 2 fatal cases.1 Usually, group A β-hemolytic streptococcus is transmitted through bodily contact and respiratory tract droplets. Hence, isolating patients and strengthening individual protection have been recommended as prevention and control measures for group A β-hemolytic streptococcus. However, empirical data to support this recommendation are limited, which could be obtained in this report. However, our data were collected retrospectively, and the relevant studies are very limited. A follow-up study with larger samples is needed to validate our finding. Wen-Xian Li, MD Hong-Mei Xu, BS Qiao Sun, BS Yi-Fei Fu, BS Yuan-Ping Wang, MS Yi Fei, BS Wei-Ping Zhu, MS Pudong New Area Center for Disease Control and Prevention Shanghai, People’s Republic of China

Maldi-Tof Mass Spectrometry-Based Identification of Group A Streptococcus Isolated from Areas of the 2011 Scarlet Fever Outbreak in China

Rapid Identification of Common Clinical Organism by Matrix-Assisted Laser Desorption/ionization Time Of-Fright Mass Spectrometry

Simultaneous Detection of Key Bacterial Pathogens Related to Pneumonia and Meningitis Using Multiplex PCR Coupled with Mass Spectrometry.

Increase of emm1 isolates among group A Streptococcus strains causing scarlet fever in Shanghai, China

Prevalence and identification of antibiotic-resistant scarlet fever group A Streptococcus strains in some paediatric cases at Shenzhen, China

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid identification of Corynebacterium species of clinical isolates

Multilocus Sequence Typing of 14 Group A Streptococcus Isolates from Children with Scarlet Fever

Report and analysis of a scarlet fever outbreak among adults through food-borne transmission in China.

Molecular Epidemiology of Group A Streptococcus Isolated from Children in Beijing during 2011 to 2019

Molecular Epidemiological Characteristics of Streptococcus Pyogenes Strains Involved in an Outbreak of Scarlet Fever in China, 2011

Evaluation of MALDI Biotyper and VITEK MS for identifying clinical isolated Streptococcus spp.

Evaluation Of An In-House Maldi-Tof Ms Rapid Diagnostic Method For Direct Identification Of Micro-Organisms From Blood Cultures

ORIGINAL RESE ARCH Performance of Two Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Systems for Identification of the Viridans Group Streptococci

Matrix-assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry for the Identification of Beta-Hemolytic Streptococci.

Analysis the Epidemiology and Drug Sensitivity of Group A Streptococcus Pyogenes Strains Isolated from Children in Partial Aeras of Shanghai

Β-Haemolytic Group A Streptococci Emm75 Carrying Altered Pyrogenic Exotoxin A Linked to Scarlet Fever in Adults

Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of coagulase-negative Staphylococci

Rapid Identification of Pathogenic Organisms Positive for Blood Culture by MALDI-TOF Mass Spec-Trometry in Combination with Sepsityper Kit or Serum-Separating Gel Tubes

Outbreak of Scarlet Fever in Pudong New Area of Shanghai, China

Rapid Identification of Methicillin-Resistant Staphylococcus Aureus and Methicillin-Sensitive Staphylo-coccus Aureus Strains by Matrix-Assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry

Clinical Application of Matrix-Assisted Laser-Resolved Ionization Time-Of-Flight Mass Spectrometry for Rapid Detection of Blood-Borne Pathogens.